Clinical Trial

A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is an Open-label ,Multicenter Study to evaluate Long-Term Safety and Efficacy of CM512 in patients with Atopic Dermatitis who have completed treatment in parent CM512 Study.
Trial Details
NCT Number NCT07230483
Lead Sponsor Keymed Biosciences Co.Ltd
Conditions Atopic Dermatitis (AD)
Enrollment 246 participants
Start Date 2025-12
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-11-17